Altimmune (ALT) Research & Development: 2010-2025
Historic Research & Development for Altimmune (ALT) over the last 16 years, with Sep 2025 value amounting to $15.0 million.
- Altimmune's Research & Development fell 24.46% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.8 million, marking a year-over-year decrease of 14.56%. This contributed to the annual value of $82.2 million for FY2024, which is 24.97% up from last year.
- According to the latest figures from Q3 2025, Altimmune's Research & Development is $15.0 million, which was down 13.20% from $17.2 million recorded in Q2 2025.
- Over the past 5 years, Altimmune's Research & Development peaked at $29.2 million during Q3 2021, and registered a low of $11.9 million during Q1 2021.
- In the last 3 years, Altimmune's Research & Development had a median value of $17.2 million in 2023 and averaged $17.8 million.
- Its Research & Development has fluctuated over the past 5 years, first spiked by 125.52% in 2021, then plummeted by 30.62% in 2022.
- Over the past 5 years, Altimmune's Research & Development (Quarterly) stood at $20.2 million in 2021, then fell by 4.98% to $19.2 million in 2022, then fell by 11.84% to $16.9 million in 2023, then increased by 16.99% to $19.8 million in 2024, then fell by 24.46% to $15.0 million in 2025.
- Its Research & Development was $15.0 million in Q3 2025, compared to $17.2 million in Q2 2025 and $15.8 million in Q1 2025.